Baird Medical Investment (BDMD) Competitors

Baird Medical Investment (NASDAQ:BDMD) and Perspective Therapeutics (NYSE:CATX) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, community ranking, valuation, earnings, risk, dividends, profitability and analyst recommendations.

Is BDMD or CATX more profitable?

Baird Medical Investment has a net margin of 0.00% compared to Perspective Therapeutics' net margin of -4,096.66%. Baird Medical Investment's return on equity of 0.00% beat Perspective Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Perspective Therapeutics	-4,096.66%	-27.40%	-23.16%

Which has stronger valuation & earnings, BDMD or CATX?

Baird Medical Investment has higher revenue and earnings than Perspective Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$33.05M	1.15	N/A	N/A	N/A
Perspective Therapeutics	$1.43M	126.87	-$46.51M	N/A	N/A

Do analysts prefer BDMD or CATX?

Perspective Therapeutics has a consensus price target of $12.75, indicating a potential upside of 420.41%. Given Perspective Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Perspective Therapeutics is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Perspective Therapeutics	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	3 Strong Buy rating(s)	3.18

Does the MarketBeat Community prefer BDMD or CATX?

Perspective Therapeutics received 33 more outperform votes than Baird Medical Investment when rated by MarketBeat users.

Company	Underperform	Outperform
Baird Medical Investment	N/A	N/A
Perspective Therapeutics	Outperform Votes 33 97.06%	Underperform Votes 1 2.94%

Do insiders & institutionals have more ownership in BDMD or CATX?

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 54.7% of Perspective Therapeutics shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 3.5% of Perspective Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media refer more to BDMD or CATX?

In the previous week, Baird Medical Investment and Baird Medical Investment both had 5 articles in the media. Perspective Therapeutics' average media sentiment score of 0.88 beat Baird Medical Investment's score of 0.66 indicating that Perspective Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Perspective Therapeutics	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, BDMD or CATX?

Baird Medical Investment has a beta of -0.73, indicating that its stock price is 173% less volatile than the S&P 500. Comparatively, Perspective Therapeutics has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.

Summary

Perspective Therapeutics beats Baird Medical Investment on 9 of the 14 factors compared between the two stocks.